Cencora's trading volume on March 5th was $606 million, a 109.07% increase compared to the previous trading day.

On March 5, 2026, healthcare and nursing products distributor Cencora (COR) recorded trading value of $606 million, ranking 243rd among U.S. stocks on that day. Trading value increased by 109.07% from the previous day, and the trading volume was 1.6957 million.

Cencora (COR) fell 2.42% on March 5, 2026, closing at $359.28. Over the past five trading days, the stock has declined 2.01%. For the entire month of March, it is down 3.46%. Year-to-date, it is up 6.37%, and over the past 52 weeks, it is up 42.84%.

*If the company has been listed for less than 52 weeks, then the 52-week gain/loss refers to the gain/loss since listing (the same applies to cases where it has been listed for less than 1 month or less than 5 trading days)

Cencora released its fiscal first-quarter report for fiscal year 2026 on February 4, 2026. Revenue for October 1, 2025 to December 31, 2025 was $786.2k, up 5.45% year over year, and net profit was $566 million, up 14.67%.

Cencora, Inc. is one of the largest pharmaceutical procurement and distribution service companies in the world, helping healthcare providers as well as pharmaceutical and biotechnology manufacturers improve patients’ access to products and strengthen the opportunity for patient care. The company offers innovative programs and services aimed at improving the effectiveness and efficiency of the pharmaceutical supply chain in human and animal health. More specifically, the company provides comprehensive branded, specialty branded, and non-proprietary prescription drug products, over-the-counter medical products, home healthcare supplies and equipment, and related services to various healthcare providers located in the United States and parts of global markets, including acute-care hospitals and health systems, independent and chain retail pharmacies, mail-order pharmacies, clinics, long-term care and alternative-site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers. In addition, the company provides various related services to healthcare providers and pharmaceutical manufacturers, including data analytics, outcomes research, reimbursement, and pharmaceutical consulting services, niche high-quality logistics services, inventory management, pharmacy automation, pharmacy management and packaging solutions.